Friday, July 10, 2026

biotech · NSCLC Stage IV · Poliomyelitis

BioMarin Pharmaceutical

Biotech Pharmaceutical Co is a biotech organization headquartered in CN. Primary therapeutic focus areas include NSCLC Stage IV, Poliomyelitis, Hyperlipidemias, Non-Hodgkin Lymphoma, Hepatocellular Carcinoma (HCC). NovaP

770 Lindaro Street, San Rafael, CA 94901, US HQ
1997 Founded
3,171 Employees
NMPA registrant Type
Company details
Status
Public
HQ
770 Lindaro Street, San Rafael, CA 94901, US
Founded
1997
Employees
3,171
Programs
40
Drugs
37
Patents
0
Clinical program

Chidamide

Phase 2 · small molecule · Hepatocellular Carcinoma (HCC)

Chidamide for Hepatocellular Carcinoma (HCC) is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

← All Biotech Pharmaceutical Co., projects Phase 2 small molecule terminated

Internal code KEPIDA-1

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Biotech Pharmaceutical Co.,
Phase
Phase 2
Modality
small_molecule
Indication
Hepatocellular Carcinoma (HCC)
Status
terminated
Trials
1

Clinical trials